Showing 101 - 110 of 47,995
Background: The necessity to measure and reward "value for money" of new pharmaceuticals has become central in health policy debates, as much as the requirement to assess the "willingness to pay" for an additional, qualityadjusted life year (QALY). There is a clear need to understand the...
Persistent link: https://www.econbiz.de/10012291180
Persistent link: https://www.econbiz.de/10011610017
Persistent link: https://www.econbiz.de/10011675238
Persistent link: https://www.econbiz.de/10012061325
Persistent link: https://www.econbiz.de/10012062372
Persistent link: https://www.econbiz.de/10012000265
Persistent link: https://www.econbiz.de/10012005044
Background: Health technology assessment (HTA) is currently one of the major challenges in assessing medical innovations and healthcare systems. In Europe, the European Network for Health Technology Assessment (EUnetHTA) has been aspiring to develop and implement standards for international...
Persistent link: https://www.econbiz.de/10011942906
Persistent link: https://www.econbiz.de/10011946183
Persistent link: https://www.econbiz.de/10011817466